Author： Lien Yeong-Hau H Lai Li-Wen
Publisher： Informa Healthcare
ISSN： 1471-2598
Source： Expert Opinion on Biological Therapy, Vol.4, Iss.6, 2004-06, pp. : 919-926
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
During the last 20 years there have been major improvements in renal replacement therapy, including dialysis and kidney transplantation; however, the treatment options for renal diseases are still limited. Gene therapy is a potential modality for many renal diseases for which we are as yet unable to offer specific treatment. This article reviews the recent data on gene therapy in animal models applicable to human renal diseases and evaluates its efficacy, safety and clinical relevance. Several approaches appear to be promising, including adeno-associated viral vectors for long-term gene expression, electroporation for muscular gene delivery, ultrasound/microbubble-mediated gene targeting, macrophage-based gene therapy and small interfering RNAs.
Related content
Gene therapy for lipoprotein disorders
By Broedl Uli C Rader Daniel J
Expert Opinion on Biological Therapy, Vol. 5, Iss. 8, 2005-08 ,pp. :
Access to resources
Recommend
Gene therapy for lysosomal storage disorders
By Barranger John A Novelli Enrico M
Expert Opinion on Biological Therapy, Vol. 1, Iss. 5, 2001-09 ,pp. :
Gene therapy for lysosomal storage disorders
Expert Opinion on Biological Therapy, Vol. 11, Iss. 9, 2011-09 ,pp. :